Trial Profile
Comparative Effectiveness Research Trial of Alzheimer's Disease Drugs.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 03 Mar 2017
Price :
$35
*
At a glance
- Drugs Donepezil (Primary) ; Galantamine (Primary) ; Rivastigmine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Acronyms COMET-AD
- 11 Apr 2016 Status changed from active, no longer recruiting to discontinued because low study accrual caused the study to be ended early.
- 02 Jun 2011 New trial record